Ningong: A speech on the research of China's online pharmacy competitiveness and its hotspot analysis

Absrtact: August 16 News, China Kang Information Chief technology officer Ninguang in the 2014 China International Conference on Electronic Commerce published the title of "Chinese Online pharmacy competitiveness Research and hot analysis" speech. 2014 Annual meeting of Chinese pharmaceutical dealers held in Boao Conference Center for Asia,

August 16 News, China Kang Information Chief technology Officer Ninguang will be in the "2014 China International Electronic Commerce Conference" published a "Chinese online pharmacy competitiveness Research and hot analysis" speech.

2014 The annual meeting of Chinese pharmaceutical dealers held in Boao Conference Center for Asia, the theme of the conference is "pharmacy mobile internet storm." The conference is one of the clubs (China Drug Retail Industry Information Conference), co-sponsored by the Chinese health information and the first pharmacy. The General Assembly set up "pharmaceutical and electronic Business policy and market environment analysis", "Pharmaceutical electric business platform strategic planning and sharing," mobile interconnection under the O2O mode sharing "and other issues, invited bat Electric quotient three giants, 200 pharmaceutical electrical business enterprises, integrated supply chain both ends Chiu Yujia Excellent enterprises to communicate in depth.

(Warm tip: This article for the first draft of shorthand, to ensure that the site guests original intention, without the omission, or a mistake, please understand.) ）

Ninguang, chief technology officer, China Health information

The following is a transcript of the speech:

Ningong: My first statement today is my personal opinion, may be many places are immature, because the whole industry I think we are involved in this actually many patterns can change, this is a lot of my understanding of the pharmaceutical industry, many may be not what we are talking about the internet thinking. So the whole industry is actually in the exploration, maybe I am talking about the characteristics of the industry to my understanding. So why to take this topic, I think now including the non-pharmaceuticals, including some clothing, food, electrical appliances, these actually develop to a certain extent how to improve the value-added services, and then to do the fastest between the distribution, before how the convenience of the Internet and cost-effective to do, Now we want to continue to provide consumers with more valuable things, this is what we call O2O, we have a lot of models, we do the downwind of the courier he also wants to open a shop, so this is also called O2O mode, and most of it is to ensure that within the community within one hours can be distributed in place, this can be done, We've got a pharmacy. This is just starting to be a platform is also through our pharmacies to patients with customers as soon as possible to provide convenience, there are some department stores, we know that Alibaba and Yintai is the exchange, this thing I think it is the two-year comparison concept is very hot, but the overall view, My understanding of our drugs is actually also its characteristics, generally speaking, for example, some of our other commodities, its convenience in addition to the convenience of cost-effective is very important.

Because I often buy things from the top of Jingdong, in addition to its price is secondary, one I care more about its distribution and quality, this piece I am more concerned about the distribution of this piece I think Jing Dong did a good job, especially its operation, so from other goods this piece of convenience is a very important indicator, But my understanding of the convenience of drugs is not an important indicator of this other drug, because the drug does not mean that we have a lot of important people, high blood pressure, diabetes and less than one can not say that blood pressure is high, or blood sugar also went up. It's more of a planning, we call it planning, this is different from other products, so this solution involves a lot of our drugs, we provide is also convenient, his problem came out, we gave the point of the merchant line, his value where, if too little of this piece for offline support too little, There will be less support offline. The same goes for our online customers, because Yaobin's own transaction times and its customer unit price may be far less than I said other goods, this piece we do another line of time, how we balance the relationship, this is what we should think.

If we were to focus on our population now, most of the people with disease, disease, and chronic disease still have a lot of value added, they need to be in medical care, check, cost control and some medication. I think we should consider how we can provide something more valuable. So the main thing I'm talking about today is that we're a pharmaceutical dealer O2O what it should be, we can also discuss together, we may have several major electric companies, including Alibaba, Tencent, Jingdong also has to do their own drug dealers, we have a lot of fear they invade us how to do, this piece don't worry, We have our advantage.

Here we talk about the o2o of drugs, we should be in the drug situation is suffering from high blood pressure, diabetes, hyperlipidemia such a patient, his monthly dosage of about 300 dollars or so about one months, I give an example, this 300 money how to allocate, he is likely to use in the three hospitals reported 70%, so that 210 dollars in the hospital to take medicine, and 90 bucks, 90 bucks. He would go to the pharmacy at this time, because the pharmacy from my data, the pharmacy in some slow sickness medication it's average price is cheaper than the hospital's tender price of 10%, this our data, if added to 15% is almost cheap 30% or so, This part of the people will go to the pharmacy almost. In this case, if we can convince these patients, for example, if we sign a deal with this patient, my membership will pay you 90 bucks for 65 bucks If you go to the big people's pharmacy. This patient, I think he's earning it, he would like to, because for example, he went to the general pharmacy to 80 yuan, if you go to the common people take a card is our member he became, so he saved, will save 25 dollars, I think this is to provide the value of patients, for the people speaking, And calculate this if I sell the drug to the patient at 65 bucks, so how many patients do I need, we pass this platform if bring him 1000 patients, he needs 2000 patients, 2000 patients he felt a little profit, plus other goods he will count the bill, I give an example, If from the cost of managing a member's patient, I think we provide a value platform, this point I understand it is a point with the platform, this time if the need for medicine, I gave him not here, I scattered in some outlets above, is this network has exclusivity, such as in Guangzhou, the people, the Big Forest, Seven to eight of the chain of Guangzhou 6,000 pharmacies, I choose the top eight chain, choose their 500 stores enough, this 500 store concentration and competitiveness is very strong, because I brought him the passenger flow, so he also willing to cooperate, this piece I think this is my understanding of the O2O, perhaps with the understanding of everyone here is still some differences.

There are other, if we have a platform, is how I may also put this crowd in the service, especially his early diagnosed diabetes, he identified diabetes may be the blood glucose index instability, the prescription for the resolution of the disease is also unstable, to often go to the hospital to do some tests to change some prescriptions finally stabilized, If we do that, maybe I'm going to arrange for him to go to the medical facility to arrange for him to meet the doctor, and if he takes the medicine, we can also make the hospital drug community the same. The hospital became a pharmacy for our clients. I am talking about is a very macro, is online to see what line.